MedChunk
Medically reviewed

How Long Do Statins Take to Lower Plaque Risk?

Learn how long statins take to lower cholesterol, stabilize artery plaque, and reduce heart attack and stroke risk, including when improvements may begin.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 12 min read

Statins begin lowering LDL (bad) cholesterol within about 2 to 4 weeks, but reducing the risks associated with artery plaque takes longer. Cholesterol levels usually show their full response within 4 to 12 weeks, while measurable plaque changes may take 6 months to 2 years or longer. Statins can also help stabilize existing plaque, making it less likely to rupture and cause a heart attack or stroke.

How Quickly Do Statins Start Protecting Your Arteries?

Statins work by reducing the amount of cholesterol the liver produces. This lowers LDL cholesterol circulating in the bloodstream, which helps limit further cholesterol buildup in artery walls.

The effects develop in stages rather than happening all at once:

  • Within 2 to 4 weeks: LDL cholesterol levels may begin to fall noticeably.
  • Within 4 to 12 weeks: The cholesterol-lowering effect approaches its maximum, depending on the medication, dose, and individual response.
  • Within several months: Sustained cholesterol reduction can contribute to changes in plaque composition and stability.
  • Over 6 months to 2 years or longer: Some people may experience measurable reductions in plaque volume with continued treatment.

The Health Service Executive (HSE) explains that cholesterol levels should drop within approximately four weeks of taking statins regularly. However, changes in a cholesterol blood test do not mean that existing artery plaque has disappeared.

Why Lower Cholesterol Does Not Mean Plaque Disappears Immediately

Artery plaque, also called atherosclerotic plaque, develops when cholesterol, fats, inflammatory cells, and other substances collect within artery walls. Over time, these deposits can narrow the arteries and interfere with blood flow.

Lowering LDL cholesterol helps reduce the amount of cholesterol available to contribute to plaque buildup. However, existing plaque is a complex structure that does not disappear as soon as cholesterol levels improve.

Statins have two important effects on this process:

1. They help prevent further plaque buildup

By reducing LDL cholesterol, statins decrease an important contributor to atherosclerosis. This helps slow the development of additional plaque and may limit the progression of existing deposits.

2. They help stabilize existing plaque

Not all artery plaques carry the same risk. Some plaques have a thin outer covering and a larger fatty core, making them more vulnerable to rupture. When a plaque ruptures, a blood clot can form and suddenly block blood flow.

Statins can help improve plaque stability by changing its composition. This may reduce the likelihood of plaque rupture, even when the overall size of the plaque has not changed significantly.

The World Health Organization (WHO) describes how statins lower LDL cholesterol and help stabilize existing plaques, contributing to a lower risk of cardiovascular events.

How Long Does It Take for Statins to Reduce Existing Plaque?

Measurable plaque regression generally takes much longer than lowering cholesterol. Research suggests that changes can become detectable after approximately 6 months of intensive treatment in some people, although the timeline varies.

A 2016 meta-analysis published in the European Heart Journal examined the effects of statin treatment on plaque regression after acute coronary syndrome. It included data from 1,623 participants across clinical trials and observational studies. The analysis found that intensive statin treatment was associated with measurable plaque regression after 6 months, with benefits maintained at 12 months.

Another systematic review, published in 2014 in the journal Atherosclerosis, examined studies of plaque regression in different arteries. Among the studies documenting regression with statin treatment, the average time to plaque regression was approximately 19.7 months.

These findings do not establish a fixed timeline for everyone. The studies involved different populations, treatment intensities, and methods of measuring plaque. Some people may experience plaque stabilization without a substantial reduction in plaque size.

The important distinction is that cardiovascular protection does not depend entirely on making existing plaque smaller. Stabilizing vulnerable plaque and preventing additional buildup are also meaningful benefits.

When Does the Risk of Heart Attack and Stroke Begin to Decrease?

The protective effects of statins develop as LDL cholesterol falls and treatment continues. However, there is no single date when everyone becomes protected from a heart attack or stroke.

Statins reduce cardiovascular risk over time by lowering LDL cholesterol and helping manage the underlying process of atherosclerosis. The size of the benefit depends on factors such as the person's starting cardiovascular risk, the amount of LDL reduction, and how consistently treatment is taken.

People who have already experienced a heart attack, stroke, or another form of cardiovascular disease may receive statins to reduce the risk of further events. In these situations, treatment is part of longer-term risk reduction rather than a short course intended to remove plaque quickly.

The NHS explains that statins are generally taken long term because continuing treatment helps keep the risk of heart attack and stroke as low as possible.

What Determines How Quickly Statins Work?

Although statins lower cholesterol in a relatively predictable period, the amount of LDL reduction and the longer-term effect on plaque can differ between individuals.

Type and intensity of statin

Different statins and doses have different cholesterol-lowering effects. Treatment is commonly classified according to the expected percentage reduction in LDL cholesterol:

  • High-intensity statins: Usually lower LDL cholesterol by 50% or more.
  • Moderate-intensity statins: Usually lower LDL cholesterol by approximately 30% to 49%.
  • Low-intensity statins: Usually lower LDL cholesterol by less than 30%.

These are expected treatment responses, not guaranteed results. The dose and type of statin are selected according to cardiovascular risk, cholesterol levels, other health considerations, and treatment tolerance.

Starting LDL cholesterol level

The amount of LDL reduction depends partly on the cholesterol level before treatment begins. Healthcare professionals compare follow-up results with the starting level to understand how well the medication is working.

Consistency in taking medication

Taking statins regularly is important for maintaining lower LDL cholesterol levels. Missing doses frequently or stopping treatment can reduce the intended cholesterol-lowering effect.

Other cardiovascular risk factors

High blood pressure, diabetes, smoking, and other cardiovascular risk factors can continue to affect heart and blood vessel health even when LDL cholesterol improves. Managing these factors alongside cholesterol is important for reducing overall cardiovascular risk.

How Do Doctors Check Whether Statins Are Working?

A cholesterol blood test, also called a lipid profile, is the main way to assess the initial response to statin treatment. It measures LDL cholesterol, HDL cholesterol, total cholesterol, and triglycerides.

Healthcare professionals commonly repeat this test 4 to 12 weeks after starting a statin or changing its dose. This helps determine whether LDL cholesterol has decreased as expected and whether the treatment needs adjustment.

The MedlinePlus Medical Encyclopedia explains that cholesterol levels are generally checked 4 to 12 weeks after starting cholesterol-lowering medication, followed by further testing approximately every 6 to 12 months.

Follow-up testing can help answer several questions:

  • Has LDL cholesterol decreased sufficiently?
  • Is the prescribed medication being taken consistently?
  • Is the current dose appropriate for the person's cardiovascular risk?
  • Would a different statin or additional cholesterol-lowering medication be appropriate?

A cholesterol test cannot directly show whether plaque has become smaller or more stable. Imaging tests may be used in selected clinical situations, but repeated artery imaging is not routinely required for everyone taking statins.

Does a Normal Cholesterol Level Mean Plaque Risk Is Gone?

No. A normal or improved LDL cholesterol level does not necessarily mean that existing artery plaque has disappeared or that cardiovascular risk has returned to zero.

Cholesterol is an important part of cardiovascular risk, but it is not the only factor. A person may still have established plaque, high blood pressure, diabetes, or other factors that contribute to heart attack and stroke risk.

For people with known cardiovascular disease, maintaining the prescribed cholesterol-lowering treatment may remain important even after blood test results improve.

Doctors also consider the person's medical history and overall cardiovascular risk when deciding what LDL cholesterol level to aim for. The target may differ depending on whether treatment is intended to prevent a first cardiovascular event or reduce the risk of another one.

How Long Should You Continue Taking Statins to Protect Your Arteries?

Statins are often prescribed as long-term treatment because their benefits depend on maintaining lower LDL cholesterol levels over time.

Stopping treatment can allow LDL cholesterol to rise again. It may also reduce the ongoing protection provided by the medication.

Even when cholesterol reaches the intended level, this does not automatically mean that the medication is no longer necessary. The decision to continue, reduce, or change treatment depends on the person's cardiovascular risk, medical history, treatment response, and any side effects.

If muscle pain, weakness, or other concerning symptoms develop after starting a statin, discuss them with a healthcare professional. The dose or medication may sometimes be adjusted to find a treatment that is better tolerated.

Do not stop or reduce a prescribed statin on your own because a cholesterol test has improved or because you feel well.

Can Lifestyle Changes Make Statins More Effective?

Healthy lifestyle habits can complement statin treatment by addressing other factors that contribute to cardiovascular disease. They do not replace a prescribed statin when medication is needed.

Helpful measures include:

  • Choose heart-healthy foods: Include vegetables, fruits, whole grains, legumes, nuts, and sources of unsaturated fats while limiting foods high in saturated and trans fats.
  • Stay physically active: Regular physical activity supports heart health and helps manage cholesterol, blood pressure, and blood sugar.
  • Avoid smoking: Smoking damages blood vessels and increases cardiovascular risk.
  • Manage blood pressure and blood sugar: Appropriate management helps address important cardiovascular risk factors.
  • Maintain a healthy weight: Weight management can support improvements in several cardiovascular risk factors.

These habits work alongside medication to support long-term cardiovascular health. Their benefits are generally greatest when maintained consistently rather than followed for only a short period.

What Should You Expect During the First Year of Statin Treatment?

The first year of treatment usually involves checking the cholesterol response, reviewing medication tolerance, and maintaining long-term cardiovascular risk reduction.

First month

LDL cholesterol may already be noticeably lower. Most people do not feel a physical difference because high cholesterol and plaque buildup generally do not cause noticeable symptoms in their early stages.

Months 2 to 3

The cholesterol-lowering effect is usually close to its maximum. A follow-up lipid profile helps the healthcare professional determine whether the treatment is achieving the intended reduction.

Months 4 to 6

Continued treatment maintains lower LDL cholesterol. Some clinical studies have detected changes in plaque volume after approximately six months of intensive statin treatment, although this does not happen uniformly.

Months 7 to 12

Longer-term treatment continues to support plaque stabilization and cardiovascular risk reduction. Follow-up appointments help assess medication adherence, cholesterol levels, and whether any treatment changes are needed.

Not everyone needs plaque imaging during this period. A person's treatment progress is generally assessed through cholesterol measurements and their overall cardiovascular risk rather than by expecting a visible change in plaque size.

Frequently Asked Questions

Common questions about how quickly statins lower plaque risk and protect the heart and blood vessels.

How long does it take for statins to start reducing plaque risk?

Statins begin lowering LDL cholesterol within approximately 2 to 4 weeks. Their effects on plaque stability and cardiovascular risk develop over a longer period. Measurable plaque changes may take 6 months to 2 years or longer, depending on treatment and individual factors.

Can statins remove existing plaque from arteries?

Statins can help reduce existing plaque volume in some people, but they do not reliably remove all plaque. Their benefits also include stabilizing existing deposits and slowing further plaque buildup.

Do statins stabilize plaque before they shrink it?

Statins can improve plaque stability without producing a large reduction in plaque size. Plaque stabilization and plaque regression are different processes, and measurable changes in plaque volume may take longer to develop.

How soon should cholesterol be checked after starting statins?

A lipid profile is commonly repeated 4 to 12 weeks after starting a statin or changing its dose. Further testing is generally performed every 3 to 12 months, depending on treatment needs and clinical circumstances.

If my cholesterol becomes normal, can I stop taking statins?

Not necessarily. Improved cholesterol levels may be the result of taking the medication, and LDL cholesterol can rise again after stopping it. Whether treatment should continue depends on your overall cardiovascular risk and medical history. Discuss any changes with your healthcare professional before stopping the medication.

Citations

  1. Health Service Executive (HSE) – How and When to Take Statins
  2. World Health Organization (WHO) – What Are Statins and Why Are They Important?
  3. European Heart Journal – The Effect of Statin Therapy on Plaque Regression Following Acute Coronary Syndrome: A Meta-Analysis of Prospective Trials
  4. Atherosclerosis – A Systematic Review of the Time Course of Atherosclerotic Plaque Regression
  5. NHS – Statins
  6. MedlinePlus Medical Encyclopedia – Cholesterol: Drug Treatment
Share this article